928 Phase I trial of the topoisomerase I inhibitor GG211 as a 72-hour infusion

• 30 November 1995
• journal article
• abstracts
• Published by Elsevier in European Journal Of Cancer
• Vol. 31, S193
• https://doi.org/10.1016/0959-8049(95)96177-f

Abstract

Keywords

• COLON
• PHASE
• GRADE
• MYELOSUPPRESSION
• INFUSION
• DOSE
• HOUR
• CANCERS
• MG/M2/DAY
• GG211